1. Home
  2. RGS vs SNTI Comparison

RGS vs SNTI Comparison

Compare RGS & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regis Corporation

RGS

Regis Corporation

N/A

Current Price

$27.74

Market Cap

66.6M

ML Signal

N/A

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$2.11

Market Cap

53.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGS
SNTI
Founded
1922
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.6M
53.6M
IPO Year
1991
N/A

Fundamental Metrics

Financial Performance
Metric
RGS
SNTI
Price
$27.74
$2.11
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.75
AVG Volume (30 Days)
10.4K
99.2K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
20.05
N/A
EPS
45.08
N/A
Revenue
$223,032,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$150.00
P/E Ratio
$0.64
N/A
Revenue Growth
13.98
N/A
52 Week Low
$15.00
$1.26
52 Week High
$31.50
$7.25

Technical Indicators

Market Signals
Indicator
RGS
SNTI
Relative Strength Index (RSI) 57.31 55.97
Support Level $26.57 $2.03
Resistance Level $29.04 $2.25
Average True Range (ATR) 0.69 0.17
MACD 0.25 0.03
Stochastic Oscillator 88.44 85.20

Price Performance

Historical Comparison
RGS
SNTI

About RGS Regis Corporation

Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

Share on Social Networks: